| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3115068
Max Phase: Preclinical
Molecular Formula: C17H15Cl2N3O4
Molecular Weight: 396.23
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C1N[C@H](C(=O)O)Cc2ncn(c2Cl)C/C=C/COc2ccc(Cl)c1c2
Standard InChI: InChI=1S/C17H15Cl2N3O4/c18-12-4-3-10-7-11(12)16(23)21-14(17(24)25)8-13-15(19)22(9-20-13)5-1-2-6-26-10/h1-4,7,9,14H,5-6,8H2,(H,21,23)(H,24,25)/b2-1+/t14-/m0/s1
Standard InChI Key: QUDCZXQWFLQTLO-YUKKFKLSSA-N
Associated Targets(Human)
Integrin alpha2/beta1 69 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 396.23 | Molecular Weight (Monoisotopic): 395.0440 | AlogP: 2.56 | #Rotatable Bonds: 1 |
| Polar Surface Area: 93.45 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.29 | CX Basic pKa: 5.17 | CX LogP: 0.82 | CX LogD: -1.16 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: 0.32 |
References
| 1. Halland N, Blum H, Buning C, Kohlmann M, Lindenschmidt A.. (2014) Small Macrocycles As Highly Active Integrin α2β1 Antagonists., 5 (2): [PMID:24900800] [10.1021/ml4004556] |
Source
Source(1):